Skip to main content

Santiago Ramon y Cajal Agüeras

Institutions of which they are part

Head of group
Translational Molecular Pathology
Vall Hebron Institut de Recerca

Santiago Ramon y Cajal Agüeras

Institutions of which they are part

Head of group
Translational Molecular Pathology
Vall Hebron Institut de Recerca

Projects

RETICS de Biobancos

IP: Santiago Ramon y Cajal Agüeras
Collaborators: Isabel Novoa Garcia, Joan Montaner Villalonga, Antonio Luis Andreu Périz, Inés de Torres Ramirez, Sara Marsal Barril, Raul Tortosa Mendez
Funding agency: Instituto de Salud Carlos III
Funding: 515890.28
Reference: RD09/0076/00066
Duration: 01/01/2010 - 31/12/2014

Correlación de la expresión de factores embudo 4EBP1, con la expresión de diferentes receptores epidérmicos: papel de HER3, HER2 y sus formas truncadas en diferentes tipos de tumor

IP: Santiago Ramon y Cajal Agüeras
Collaborators: Josep Castellví Vives, Javier Hernandez Losa
Funding agency: Fundación Invest. Médica Mutua Madrileña
Funding: 75000
Reference: FMMA/13/2008
Duration: 30/07/2008 - 29/07/2011

Factores centrales o embudos en vías de señalización y senescencia: estudio molecular de las vías de activación e inhibición de receptores epidérmicos y de 4EBP1 y el F4E, así como de RSK4 en senescencia

IP: Santiago Ramon y Cajal Agüeras
Collaborators: Cleofé Romagosa Pérez-Portabell, Carmela Iglesias i Felip, Elena Antima Martinez Saez, Vicente Peg Camara
Funding agency: Instituto de Salud Carlos III
Funding: 147862
Reference: PI08/0143
Duration: 01/01/2009 - 31/12/2011

Organització de la 4a. reunió de la Xarxa CAHODE (Càncers Hormono-Depenents)

IP: Santiago Ramon y Cajal Agüeras
Collaborators: -
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 4500
Reference: 2008ARCS100157
Duration: 25/09/2008 - 26/09/2008

Related news

The ten groups within the Cancer Area combine basic, translational and clinical research to identify new targets, biomarkers and therapeutic strategies

The grants promote new therapeutic strategies and diagnostic tools in highly complex tumors such as glioblastoma, triple-negative breast cancer, and endometrial cancer.

The Department of Health of the Generalitat de Catalunya grants subsidies for carrying out validation tests on innovative projects in the field of health that are in the early stages of development.

Related professionals

Micaela Cecilia Abud

Micaela Cecilia Abud

Gestió i Administració
Infrastructure Coordination
Manager
Read more
Estefa Cuba Choque

Estefa Cuba Choque

Maintenance staff and general services
Infectious Diseases
Read more
Katerina Papadakis

Katerina Papadakis

Gestió i Administració
Internal Strategy Directorate
Read more
Jose Fernando Rodríguez Palomares

Jose Fernando Rodríguez Palomares

Main researcher
Cardiovascular Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.